Avanos Medical, Inc. v. Stratus Medical, LLC

IPR2024-01212

The PTAB found all 29 challenged claims unpatentable by a preponderance of evidence. The Board rejected the Patent Owner's argument that the invention was limited to RF neurotomy, adopting Petitioner's broader view of 'thermal ablation systems.'

Jurisdiction
US PTAB
Case Number
IPR2024-01212
Judge(s)
Michael J. Fitzpatrick, Susan L.C. Mitchell, Arthur M. Peslak
Decision Date
26 July 2024

Detailed Summary

In this final written decision, the PTAB determined that the 29 claimed methods for RF neurotomy using deployable filaments were obvious over prior art references (Racz, Fitz, Lee). The Board found motivation to combine Racz with the teachings of Fitz and Lee, which addressed energy coverage and filament control in thermal ablation systems. Crucially, the Board rejected the Patent Owner's attempt to narrow the scope of the invention solely to RF neurotomy, thereby broadening the field of inquiry and supporting the finding of obviousness under 35 U.S.C. § 103.

Practitioner Note

This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Avanos Medical, Inc. vs Stratus Medical, LLC is valuable context for structuring arguments or assessing risk in similar proceedings.

Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →

Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.

Strategy Consult

Facing a similar patent matter?

Arctic's litigation team uses precedent data like this to build winning arguments.

Get a Strategy Call